Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients

Saudi Pharmaceutical Journal

Volumn 19, Issue 1, 2011, Pages 9-17

  Abdel Bari, A ^a   Mokhtar, M Sherif ^b   Sabry, Nagwa Ali ^c   El Shafi, Sanaa Abd ^d   Bazan, Naglaa Samir ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c African Union Organization St Abbassia   (Egypt)

^d BENI SUEF UNIVERSITY   (Egypt)

Author keywords

Aminoglycosides; Critically ill; Once daily; Pharmacokinetics

Indexed keywords

AMIKACIN; GENTAMICIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY;

EID: 78650625000     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2010.11.001     Document Type: Article

References (42)

1. Bartal C., Danon A., Schlaeffer F., Reisberg K., Alkan M., Smoliakov R., Sidi A., Almog Y. Pharamacokinetic dosing of aminoglycosides: a controlled trial. Am. J. Med. 2003, 114:194-198.
2. Barza M., Brown R.B., Shen D., Gibaldi M., Weinstein L. Predictability of blood levels of gentamicin in man. J. Infect. Dis. 1975, 132:165-174.
3. Begg E.J., Barclay M.L., Duffull S.B. A suggested approach to once daily aminoglycoside dosing. Br. J. Clin. Pharmacol. 1995, 39:605-609.
4. Beucaire G., Leroy O., Beauscart C., Karp P., Chidiac C., Caillaux M. Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections. J. Antimicrob. Chemother. 1991, 27(Suppl. C):91-103. The Study Group.
5. Dahlgren J.G., Anderson E.T., Hewlitt W.L. Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob. Agents Chemother. 1975, 8:58-62.
6. Dorman T., Swoboda S., Zarfeshenfard F., Trentler B., Lipsett P.A. Impact of altered aminoglycoside volume of distribution on the adequancy of a three milligram per kilogram loading dose. Surgery 1998, 124:73-78.
7. Durante-Mangoni E., Grammatikos A., Utili R., Falagas M.E. Do we still need the aminoglycosides?. Int. J. Antimicrob. Agents 2008.
8. Eltahawy A.T., Bahnassy A.A. Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a University Hospital in Saudi Arabia. J. Chemother. 1996, 8(4):278-283.
9. EORTC International Antimicrobial Therapy Cooperative Group Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann. Intern. Med. 1993, 119:584-593.
10. Erdman S.M., Rodvold K.A., Pryka R.D. An updated comparison of drug dosing methods. Part III: Aminoglycosides antibiotics. Clin. Pharmacokinet. 1991, 20:374-388.
11. Freeman C.D., Nicolau D.P., Belliveau P.P., Nightingale C.H. Once daily dosing of aminoglycosides: review and recommendations for the clinical practice. J. Antimicrob. Chemother. 1997, 39:677-686.
12. Giamarellou H., Yiallouros K., Petrikkos G., Moschovakis E., Vavouraki E., Voutsinas D., Sfikakis P. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections. J. Antimicrob. Chemother. 1991, 27(Suppl. C):73-79.
13. Gilbert D.N. Once daily aminoglycoside therapy. J. Antimicrob. Chemother. 1991, 35(3):399-405.
14. Goldman M.P., Fuller M.A. A practical alternative to conventional aminoglycoside dosing methods. Ann. Pharmacother. 1993, 27:1333.
15. Hosokawa H., Nakamura K., Mifune K., Nakano S. Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression. Chronobiol. Int. 1993, 10:259-270.
16. Huber L. Validation of computerized analytical systems. Installation and operational qualifications. LC-GC Magazine 1996, 14(9):806-812.
17. Humes H.D. Aminoglycoside nephrotoxicity. Kidney Int. 1997, 33:900-911.
18. Jackson G.G., Arcieri G. Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J. Infect. Dis. 1971, 124(Suppl.):130-137.
19. Jikoo J., Tight R., Rajkumar V., Hawa Z., Fargo Comparison of once daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Am. J. Med. 1996, 101:177-183.
20. Klastersky J., Daneau D., Swings G., Weerts D. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J. Infect. Dis. 1974, 129:187-193.
21. Maglio D., Nightingale C.H., Nicolau D.P. Extended interval aminoglycoside dosing. From concept to clinic. Int. J. Antimicrob. Agents 2002, 19:341-348.
22. Maire P.H., Corvaisier S., Rougier F., Bouvier D'Yvoire M., Claude D., Barbaut X., Carret G., Jehl F., Ducher M., Jelliffe R.W. Pharmacocinetiques/parmacodynamie clinique des antibiotiques. Precis de Bacteriologie Clinique 2000, 715-731. Elsevier, Paris. J. Freney, F. Renaud, W. Hansen, C. Bollet (Eds.).
23. Maller R., Isaksson B., Nilsson L., Soren L. A study of amikacin given once versus twice daily in serious infections. J. Antimicrob. Chemother. 1988, 22:75-79.
24. Mendu D.R., Chou P.P., Soldin S.J. An improved application for the enzyme multiplied immunoassay technique for caffeine, amikacin and methotrexate assays on the Dade-Behring dimension RXL max clinical chemistry system. Ther. Drug Monit. 2007, 29(5):632-637.
25. Murry K.R., Mckinnon P.S., Mitrzyk B., Rybak M.J. Pharmacodynamic characterization of nephrotoxicity associated with once daily aminoglycoside. Pharmacotherapy 1999, 19(11):1252-1260.
26. Nicolau D.P., Freeman C.D., Belliveau P.P., Nightingale C.H., Ross J.W., Quintiliani R. Experience with a once daily aminoglycoside program administered to 2184 adult patients. Antimicrob. Agents Chemother. 1995, 39:650-655.
27. Nishihara K. Enzyme immunouassay of drug in blood (serum). Nippon Rinsho 1995, 53(9):2301-2309.
28. Nordstrom L., Ringberg H., Cronberg S., Tjernstrom O., Walder M. Does the administration of an aminoglycoside in a single dose affect its efficacy and toxicity?. J. Antimicrob. Chemother. 1990, 25:150-173.
29. Pariat C., Cambar J., Courtois P. Circadian variations in the acute toxicity of three aminoglycosides: gentamicin, dibekacin, and netilmicin in mice. Annu. Rev. Chronopharmacol. 1984, 1:381-384.
30. Pariat C., Courtois P., Cambar J., Piriou A., Bouquet S. Circadian variations in the renal toxicology of gentamicin in rats. Toxicol. Lett. 1988, 40:175-182.
31. Prins J.M., Boller H.R., Kvijper E.J., Tange R.A., Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993, 341:335-339.
32. Prins J.M., Weverling G.J., Van Ketel R.J., Spealman P. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients. Clin. Pharmacol. Ther. 1997, 62:106-111.
33. Raz R., Adawi M., Romano S. Intravenous administration of gentamicin once daily versus thrice daily in adults. Eur. J. Clin. Microbiol. Infect. Dis. 1995, 14:88-91.
34. Rybak M.J., Abate B.J., Kang S.L., Ruffing M.J., Lerner S.A., Drusano G.L. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob. Agents Chemother. 1999, 43(7):1549-1555.
35. Sawchuk R.J., Zaske D.E. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J. Pharmacokinet. Biopharm. 1976, 4:183-195.
36. Schentagjj J.J. Aminoglycosides. Applied Pharmacokinetics 1980, 174. Applied Therapeutics Inc., Spokane. first ed. W.E. Evans, J.J. Schentag, W.J. Jusko (Eds.).
37. Trenika M., Kazumi M., Kelly M.S. Once daily aminoglycoside administration. Orthopedics 2005, 28(2):125-127.
38. Ward K., Theiler R.N. Once-daily dosing of gentamicin in obstetrics and gynecology. Clin. Obstet. Gynecol. 2008, 51(3):498-506.
39. Watling S.M., Dasta J.F. Aminoglycoside dosing considerations in intensive care unit patients. Ann. Pharmacother. 1993, 27(3):351-357.
40. Zaske D. Aminoglycosides. Applied Pharmacokinetics 1986, 331. Applied Therapeutics Inc., Spokane. second ed. W.E. Evans, J.J. Schentag, W.J. Jusko (Eds.).
41. Zaske D.E., Cipolle R.J., Rotschafer J.C., Solem L.D., Mosier N.R., Strate R.G. Gentamicin pharmacokinetics in 1640 patients: method for control of serum concentrations. Antimicrob. Agents Chemother. 1982, 21:407-411.
42. Zaske D.E., Shikuma L.R., Tholl D.A. Antibiotics and other anti-infective agents: aminoglycosides. A Textbook for the Clinical Application of Therapeutic Drug Monitoring 1986, 285-320. Abbott Laboratories. W.J. Taylor, M.H. Caviness (Eds.).